Trial intelligence / Profile preview

Ondansetron With Olanzapine for Alcohol Dependence

NCT00678457Phase 2Completed

Sponsor
University of Virginia
Start
Jan 2007
Primary completion
May 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in alcohol dependence comparing ondansetron/olanzapine with placebo (2 arms). Primary endpoint: Decrease self-reported heavy drinking. Started Jan 2007; status: completed.

02

Drugs

ondansetronolanzapine
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT00678457.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00678457.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call